Equity Overview
Price & Market Data
Price: $24.05
Daily Change: +$0.78 / 3.24%
Daily Range: $24.05 - $24.05
Market Cap: $2,886,256,896
Daily Volume: 379
Performance Metrics
1 Week: 9.10%
1 Month: -3.04%
3 Months: -22.95%
6 Months: 16.82%
1 Year: 62.73%
YTD: -19.87%
Company Details
Employees: 354
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.